0001855763-24-000003.txt : 20240502
0001855763-24-000003.hdr.sgml : 20240502
20240502141808
ACCESSION NUMBER: 0001855763-24-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240502
DATE AS OF CHANGE: 20240502
EFFECTIVENESS DATE: 20240502
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lexaria Bioscience Corp.
CENTRAL INDEX KEY: 0001348362
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 202000871
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0831
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-512223
FILM NUMBER: 24907226
BUSINESS ADDRESS:
STREET 1: 100 - 740 MCCURDY ROAD
CITY: KELOWNA
STATE: A1
ZIP: V1X 2P7
BUSINESS PHONE: 250-765-6424
MAIL ADDRESS:
STREET 1: 100 - 740 MCCURDY ROAD
CITY: KELOWNA
STATE: A1
ZIP: V1X 2P7
FORMER COMPANY:
FORMER CONFORMED NAME: LEXARIA CORP.
DATE OF NAME CHANGE: 20080229
FORMER COMPANY:
FORMER CONFORMED NAME: Lexaria Corp.
DATE OF NAME CHANGE: 20051229
D
1
primary_doc.xml
X0708
D
LIVE
0001348362
Lexaria Bioscience Corp.
100 - 740 MCCURDY ROAD
KELOWNA
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
250-765-6424
NEVADA
LEXARIA CORP.
Lexaria Corp.
Corporation
true
Christopher
Bunka
100 - 740 McCurdy Road
Kelowna
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Executive Officer
Director
John
Docherty
100 - 740 McCurdy Road
Kelowna
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Executive Officer
Director
Nelson
Cabatuan
100 - 740 McCurdy Road
Kelowna
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Executive Officer
NICHOLAS
BAXTER
100 - 740 McCurdy Road
Kelowna
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Director
TED
MCKECHNIE
100 - 740 McCurdy Road
Kelowna
A1
BRITISH COLUMBIA, CANADA
V1Y 2P7
Director
ALBERT
REESE
100 - 740 McCurdy Road
Kelowna
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Director
CATHERINE
TURKEL
100 - 740 McCurdy Road
Kelowna
A1
BRITISH COLUMBIA, CANADA
V1X 2P7
Director
Pharmaceuticals
$1 - $1,000,000
- 06b
false
2024-04-30
false
true
false
0
H.C. WAINWRIGHT & CO.
375
None
None
430 Park Avenue
4th Floor
New York
NY
NEW YORK
10022
NY
NEW YORK
false
364629
364629
0
Warrants were issued at nominal amount of $0.125 per warrant as an inducement for the exercise of previously issued warrants
false
1
150000
0
This fee was paid as a tail commission on the proceeds received from the warrant exercises that occurred as part of the inducement and on the nominal proceeds received
0
false
Lexaria Bioscience Corp.
/Christopher Bunka/
Christopher Bunka
CEO
2024-05-02